Fed. Circ. Urged To Restore Narcan Patents
Adapt Pharma has urged the Federal Circuit to overturn a New Jersey federal court's decision that struck down parts of four patents for the opioid overdose medication Narcan, saying the ruling...To view the full article, register now.
Already a subscriber? Click here to view full article